Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Emergence and spread of resistant N. meningitidis implicated in invasive meningococcal diseases during the past decade (2008-2017).

Authors:
Yassine Zouheir Taha Atany Najma Boudebouch

J Antibiot (Tokyo) 2019 03 27;72(3):185-188. Epub 2018 Nov 27.

Laboratory of Bacteriology and Parasitology, Institut Pasteur du Maroc, Casablanca, Morocco.

Neisseria meningitidis is one of the most crucial causes of bacterial meningitis worldwide. The incidence of meningitis due to N. meningitidis greatly changes from one geographical area to the other: 500,000-1,200,000 invasive meningococcal diseases occur each year, with 50,000-135,000 deaths. Once the diagnosis of bacterial meningitis is made, parenteral antibiotic treatment is started as soon as possible. A preventive treatment can also be proposed for those subjects at risk of exposure. Globally, resistance to antibiotics used in the treatment of prophylaxis of meningococcal disease is relatively rare. Penicillin is becoming less useful in the treatment of invasive meningococcal diseases because meningococcal isolates are increasingly less susceptible to this antibiotic. Meningococcal strains less susceptible to ceftriaxone or ciprofloxacin are rare. In addition, resistance to rifampicin is not a current concern as resistant isolates are rarely reported. In conclusion, the emergence of new meningococcal strains with decreasing susceptibility during the last decade should not be ignored, as this could be a worrying phenomenon in the future and justifies a judicious epidemiological survey on a continuous basis.

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41429-018-0125-0DOI Listing
March 2019

Publication Analysis

Top Keywords

meningococcal diseases
12
invasive meningococcal
12
meningococcal strains
8
bacterial meningitis
8
meningococcal
7
resistance rifampicin
4
proposed subjects
4
ciprofloxacin rare
4
treatment proposed
4
rare addition
4
preventive treatment
4
started preventive
4
addition resistance
4
treatment started
4
continuous basis
4
antibiotic treatment
4
treatment
4
parenteral antibiotic
4
rifampicin current
4
meningitis parenteral
4

Keyword Occurance

Similar Publications

Effect of COVID-19 restrictions and border closures on vaccine preventable diseases in Victoria, Australia, 2020-2021.

Authors:
Paraag Bhatt Janet Strachan Marion Easton Lucinda Franklin George Drewett

Commun Dis Intell (2018) 2022 May 19;46. Epub 2022 May 19.

Department of Health, Victoria, Australia.

Background: In 2020, Victoria introduced multiple interventions aimed at containing the spread of coronavirus disease 2019 (COVID-19). We examine the effect of these restrictions on other vaccine preventable diseases (VPDs).

Methods: We analysed the mandatory reporting data, notified to the Victorian Department of Health, for VPDs from January 2015 to December 2021. Read More

View Article and Full-Text PDF
May 2022
Similar Publications

Is there a real risk of bacterial infection in patients receiving targeted and biological therapies?

Authors:
Ivan Noreña Mario Fernández-Ruiz José María Aguado

Enferm Infecc Microbiol Clin (Engl Ed) 2022 May;40(5):266-272

Unit of Infectious Diseases, Hospital Universitario "12 de Octubre", Instituto de Investigación Sanitaria Hospital "12 de Octubre" (imas12), Madrid, Spain; School of Medicine, Universidad Complutense. Madrid, Spain.

Over the past decades, the advent of targeted and biological therapies has revolutionized the management of cancer and autoimmune, hematological and inflammatory conditions. Although a large amount of information is now available on the risk of opportunistic infections associated with some of these agents, the evidence regarding the susceptibility to bacterial infections is more limited. Biological agents have been shown to entail a variable risk of bacterial infections in pivotal randomized clinical trials and post-marketing studies. Read More

View Article and Full-Text PDF
May 2022
Similar Publications

Invasive meningococcal disease and genome databases.

Authors:
Jens Karlsson Hannes Eichner Edmund Loh

Lancet Microbe 2021 Sep 9;2(9):e421-e422. Epub 2021 Jul 9.

Department of Microbiology, Tumour, and Cell Biology, Karolinska Institutet, Stockholm, Sweden; Clinical Microbiology, BioClinicum, Karolinska University Hospital, Stockholm, Sweden; Singapore Centre for Environmental Life Sciences Engineering, Nanyang Technological University, Singapore. Electronic address:

View Article and Full-Text PDF
September 2021
Similar Publications

Meningococcal B vaccine effectiveness.

Authors:
Angelika Banzhoff Federico Martinón-Torres

J Pediatr 2022 05;244:250-254

Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain.

View Article and Full-Text PDF
May 2022
Similar Publications

The Host-Pathogen Interactions and Epicellular Lifestyle of .

Authors:
August Mikucki Nicolie R McCluskey Charlene M Kahler

Front Cell Infect Microbiol 2022 22;12:862935. Epub 2022 Apr 22.

Marshall Centre for Infectious Diseases Research and Training, School of Biomedical Sciences, University of Western Australia, Perth, WA, Australia.

is a gram-negative diplococcus and a transient commensal of the human nasopharynx. It shares and competes for this niche with a number of other species including and . Unlike these other members of the genus, may become invasive, crossing the epithelium of the nasopharynx and entering the bloodstream, where it rapidly proliferates causing a syndrome known as Invasive Meningococcal Disease (IMD). Read More

View Article and Full-Text PDF
May 2022
Similar Publications
}
© 2022 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap